Brass Sheet and Strip From France, Germany, Italy and Japan; Scheduling of Expedited Five-Year Reviews, 10380-10381 [2023-03433]
Download as PDF
<![CDATA[
10380
Federal Register / Vol. 88, No. 33 / Friday, February 17, 2023 / Notices
lotter on DSK11XQN23PROD with NOTICES1
FID’s findings but requests vacatur of
such findings in view of the impending
expiration of that patent on January 27,
2023.
On October 11, 2022, Respondent
filed a response to Complainant’s
petition. The parties did not file a
statement on the public interest
pursuant to Commission Rule 210.50
(19 CFR 210.50). Nor has the
Commission received any submission in
response to its post-RD Federal Register
notice. See 87 FR 65249–50 (Oct. 28,
2022).
Having examined the record of this
investigation, including the FID and the
parties’ submissions, the Commission
has determined to review the FID in
part, and upon review, to affirm the
FID’s determination of no violation of
section 337. Specifically, as explained
in the Commission Opinion issued
concurrently herewith, the Commission
has determined to review and, on
review, to vacate the FID’s findings as
to the ’219 patent in view of the
expiration of that patent during the
pendency of the investigation. As to the
’788 patent, the Commission has
determined to review and, on review, to:
(1) modify and supplement the FID’s
claim construction findings with respect
to the term ‘‘common reference
frequency’’; (2) affirm with modification
the FID’s non-infringement findings; (3)
affirm with modification the FID’s
findings on the technical prong of the
domestic industry requirement; (4) take
no position as to the economic prong of
the domestic industry requirement; and
(5) reverse the FID’s invalidity findings
over Carrender I. The Commission
adopts all findings in the FID that are
not inconsistent with the Commission’s
determination.
The investigation is terminated.
The Commission’s vote for this
determination took place on February
13, 2023.
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended (19 U.S.C. 1337), and in part
210 of the Commission’s Rules of
Practice and Procedure (19 CFR part
210).
By order of the Commission.
Issued: February 13, 2023.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2023–03349 Filed 2–16–23; 8:45 am]
BILLING CODE 7020–02–P
VerDate Sep<11>2014
17:13 Feb 16, 2023
Jkt 259001
INTERNATIONAL TRADE
COMMISSION
[Investigation Nos. 731–TA–313–314, 317,
and 379 (Fifth Review)]
Brass Sheet and Strip From France,
Germany, Italy and Japan; Scheduling
of Expedited Five-Year Reviews
United States International
Trade Commission.
ACTION: Notice.
AGENCY:
The Commission hereby gives
notice of the scheduling of expedited
reviews pursuant to the Tariff Act of
1930 (‘‘the Act’’) to determine whether
revocation of the antidumping duty
orders on brass sheet and strip from
France, Germany, Italy and Japan would
be likely to lead to continuation or
recurrence of material injury within a
reasonably foreseeable time.
DATES: December 6, 2022.
FOR FURTHER INFORMATION CONTACT:
(Caitlyn Hendricks-Costello-(202) 205–
2058), Office of Investigations, U.S.
International Trade Commission, 500 E
Street SW, Washington, DC 20436.
Hearing-impaired persons can obtain
information on this matter by contacting
the Commission’s TDD terminal on 202–
205–1810. Persons with mobility
impairments who will need special
assistance in gaining access to the
Commission should contact the Office
of the Secretary at 202–205–2000.
General information concerning the
Commission may also be obtained by
accessing its internet server (https://
www.usitc.gov). The public record for
this proceeding may be viewed on the
Commission’s electronic docket (EDIS)
at https://edis.usitc.gov.
SUPPLEMENTARY INFORMATION:
Background.—On December 6, 2022,
the Commission determined that the
domestic interested party group
response to its notice of institution (87
FR 53785, September 1, 2022) of the
subject five-year reviews was adequate
and that the respondent interested party
group response was inadequate. The
Commission did not find any other
circumstances that would warrant
conducting full reviews.1 Accordingly,
the Commission determined that it
would conduct expedited reviews
pursuant to section 751(c)(3) of the
Tariff Act of 1930 (19 U.S.C. 1675(c)(3)).
For further information concerning
the conduct of these reviews and rules
of general application, consult the
Commission’s Rules of Practice and
SUMMARY:
1 A record of the Commissioners’ votes and any
individual Commissioner’s statements will be
available from the Office of the Secretary and at the
Commission’s website.
PO 00000
Frm 00100
Fmt 4703
Sfmt 4703
Procedure, part 201, subparts A and B
(19 CFR part 201), and part 207,
subparts A, D, E, and F (19 CFR part
207).
Staff report.—A staff report
containing information concerning the
subject matter of the reviews has been
placed in the nonpublic record, and will
be made available to persons on the
Administrative Protective Order service
list for these reviews on February 22,
2023. A public version will be issued
thereafter, pursuant to § 207.62(d)(4) of
the Commission’s rules.
Written submissions.—As provided in
§ 207.62(d) of the Commission’s rules,
interested parties that are parties to the
reviews and that have provided
individually adequate responses to the
notice of institution,2 and any party
other than an interested party to the
reviews may file written comments with
the Secretary on what determination the
Commission should reach in the
reviews. Comments are due on or before
March 2, 2023 and may not contain new
factual information. Any person that is
neither a party to the five-year reviews
nor an interested party may submit a
brief written statement (which shall not
contain any new factual information)
pertinent to the reviews by March 2,
2023. If comments contain business
proprietary information (BPI), they must
conform with the requirements of
§§ 201.6, 207.3, and 207.7 of the
Commission’s rules. The Commission’s
Handbook on Filing Procedures,
available on the Commission’s website
at https://www.usitc.gov/documents/
handbook_on_filing_procedures.pdf,
elaborates upon the Commission’s
procedures with respect to filings.
In accordance with §§ 201.16(c) and
207.3 of the rules, each document filed
by a party to the reviews must be served
on all other parties to the reviews (as
identified by either the public or BPI
service list), and a certificate of service
must be timely filed. The Secretary will
not accept a document for filing without
a certificate of service.
Determination.—The Commission has
determined these reviews are
extraordinarily complicated and
therefore has determined to exercise its
authority to extend the review period by
up to 90 days pursuant to 19 U.S.C.
1675(c)(5)(B).
Authority: These reviews are being
conducted under authority of title VII of
the Tariff Act of 1930; this notice is
2 The Commission has found the responses
submitted on behalf of Aurubis Buffalo, Inc., Heyco
Metals, Inc., PMX Industries, Inc., and Wieland
Holdings, Inc. to be individually adequate.
Comments from other interested parties will not be
accepted (see 19 CFR 207.62(d)(2)).
E:\FR\FM\17FEN1.SGM
17FEN1
10381
Federal Register / Vol. 88, No. 33 / Friday, February 17, 2023 / Notices
published pursuant to § 207.62 of the
Commission’s rules.
By order of the Commission.
Issued: February 14, 2023.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2023–03433 Filed 2–16–23; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1147]
Importer of Controlled Substances
Application: Sigma Aldrich Company
LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Sigma Aldrich Company LLC
has applied to be registered as an
importer of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
SUMMARY:
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before March 20, 2023. Such
persons may also file a written request
for a hearing on the application on or
before March 20, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
In
accordance with 21 CFR 1301.34(a), this
is notice that on January 11, 2023,
Sigma Aldrich Company LLC, 3500
Dekalb Street, Saint Louis, Missouri
63118–4103, applied to be registered as
an importer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Drug code
lotter on DSK11XQN23PROD with NOTICES1
Cathinone ........................................................................................................................................................................
Methcathinone .................................................................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ....................................................................................................................
Gamma Hydroxybutyric Acid ...........................................................................................................................................
Tetrahydrocannabinols ....................................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine .............................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine ..........................................................................................................................
2,5-Dimethoxyamphetamine ............................................................................................................................................
3,4-Methylenedioxyamphetamine ....................................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine .......................................................................................................................
3,4-Methylenedioxymethamphetamine ............................................................................................................................
4-Methoxyamphetamine ..................................................................................................................................................
Dimethyltryptamine ..........................................................................................................................................................
N-Benzylpiperazine ..........................................................................................................................................................
Heroin ..............................................................................................................................................................................
Normorphine ....................................................................................................................................................................
Amobarbital ......................................................................................................................................................................
Secobarbital .....................................................................................................................................................................
Nabilone ...........................................................................................................................................................................
Phencyclidine ...................................................................................................................................................................
Ecgonine ..........................................................................................................................................................................
Ethylmorphine ..................................................................................................................................................................
Levorphanol .....................................................................................................................................................................
Meperidine .......................................................................................................................................................................
Thebaine ..........................................................................................................................................................................
Opium, powdered ............................................................................................................................................................
Levo-alphacetylmethadol .................................................................................................................................................
The company plans to import the
listed controlled substances for sale to
research facilities for drug testing and
analysis. In reference to drug code 7370
(Tetrahydrocannabinols) the company
plans to import synthetic
Tetrahydrocannabinols. No other
activities for these drug codes are
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
VerDate Sep<11>2014
17:13 Feb 16, 2023
Jkt 259001
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023–03402 Filed 2–16–23; 8:45 am]
BILLING CODE P
PO 00000
Frm 00101
Fmt 4703
Sfmt 4703
1235
1237
1248
2010
7370
7391
7392
7396
7400
7404
7405
7411
7435
7493
9200
9313
2125
2315
7379
7471
9180
9190
9220
9230
9333
9639
9648
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1148]
Bulk Manufacturer of Controlled
Substances Application: Veranova,
L.P.
Drug Enforcement
Administration, Justice.
AGENCY:
E:\FR\FM\17FEN1.SGM
17FEN1
]]>Agencies
[Federal Register Volume 88, Number 33 (Friday, February 17, 2023)]
[Notices]
[Pages 10380-10381]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-03433]
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation Nos. 731-TA-313-314, 317, and 379 (Fifth Review)]
Brass Sheet and Strip From France, Germany, Italy and Japan;
Scheduling of Expedited Five-Year Reviews
AGENCY: United States International Trade Commission.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Commission hereby gives notice of the scheduling of
expedited reviews pursuant to the Tariff Act of 1930 (``the Act'') to
determine whether revocation of the antidumping duty orders on brass
sheet and strip from France, Germany, Italy and Japan would be likely
to lead to continuation or recurrence of material injury within a
reasonably foreseeable time.
DATES: December 6, 2022.
FOR FURTHER INFORMATION CONTACT: (Caitlyn Hendricks-Costello-(202) 205-
2058), Office of Investigations, U.S. International Trade Commission,
500 E Street SW, Washington, DC 20436. Hearing-impaired persons can
obtain information on this matter by contacting the Commission's TDD
terminal on 202-205-1810. Persons with mobility impairments who will
need special assistance in gaining access to the Commission should
contact the Office of the Secretary at 202-205-2000. General
information concerning the Commission may also be obtained by accessing
its internet server (https://www.usitc.gov). The public record for this
proceeding may be viewed on the Commission's electronic docket (EDIS)
at https://edis.usitc.gov.
SUPPLEMENTARY INFORMATION:
Background.--On December 6, 2022, the Commission determined that
the domestic interested party group response to its notice of
institution (87 FR 53785, September 1, 2022) of the subject five-year
reviews was adequate and that the respondent interested party group
response was inadequate. The Commission did not find any other
circumstances that would warrant conducting full reviews.\1\
Accordingly, the Commission determined that it would conduct expedited
reviews pursuant to section 751(c)(3) of the Tariff Act of 1930 (19
U.S.C. 1675(c)(3)).
---------------------------------------------------------------------------
\1\ A record of the Commissioners' votes and any individual
Commissioner's statements will be available from the Office of the
Secretary and at the Commission's website.
---------------------------------------------------------------------------
For further information concerning the conduct of these reviews and
rules of general application, consult the Commission's Rules of
Practice and Procedure, part 201, subparts A and B (19 CFR part 201),
and part 207, subparts A, D, E, and F (19 CFR part 207).
Staff report.--A staff report containing information concerning the
subject matter of the reviews has been placed in the nonpublic record,
and will be made available to persons on the Administrative Protective
Order service list for these reviews on February 22, 2023. A public
version will be issued thereafter, pursuant to Sec. 207.62(d)(4) of
the Commission's rules.
Written submissions.--As provided in Sec. 207.62(d) of the
Commission's rules, interested parties that are parties to the reviews
and that have provided individually adequate responses to the notice of
institution,\2\ and any party other than an interested party to the
reviews may file written comments with the Secretary on what
determination the Commission should reach in the reviews. Comments are
due on or before March 2, 2023 and may not contain new factual
information. Any person that is neither a party to the five-year
reviews nor an interested party may submit a brief written statement
(which shall not contain any new factual information) pertinent to the
reviews by March 2, 2023. If comments contain business proprietary
information (BPI), they must conform with the requirements of
Sec. Sec. 201.6, 207.3, and 207.7 of the Commission's rules. The
Commission's Handbook on Filing Procedures, available on the
Commission's website at https://www.usitc.gov/documents/handbook_on_filing_procedures.pdf, elaborates upon the Commission's
procedures with respect to filings.
---------------------------------------------------------------------------
\2\ The Commission has found the responses submitted on behalf
of Aurubis Buffalo, Inc., Heyco Metals, Inc., PMX Industries, Inc.,
and Wieland Holdings, Inc. to be individually adequate. Comments
from other interested parties will not be accepted (see 19 CFR
207.62(d)(2)).
---------------------------------------------------------------------------
In accordance with Sec. Sec. 201.16(c) and 207.3 of the rules,
each document filed by a party to the reviews must be served on all
other parties to the reviews (as identified by either the public or BPI
service list), and a certificate of service must be timely filed. The
Secretary will not accept a document for filing without a certificate
of service.
Determination.--The Commission has determined these reviews are
extraordinarily complicated and therefore has determined to exercise
its authority to extend the review period by up to 90 days pursuant to
19 U.S.C. 1675(c)(5)(B).
Authority: These reviews are being conducted under authority of
title VII of the Tariff Act of 1930; this notice is
[[Page 10381]]
published pursuant to Sec. 207.62 of the Commission's rules.
By order of the Commission.
Issued: February 14, 2023.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2023-03433 Filed 2-16-23; 8:45 am]
BILLING CODE 7020-02-P
